1,4-Diazabicyclo(3.2.2)nonane → HCID 68328293, compound
Reaction equation
[C:1](Cl)(=[O:15])[O:2][C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=1.[N:17]12[CH2:25][CH2:24][CH:21]([CH2:22][CH2:23]1)[NH:20][CH2:19][CH2:18]2>>[N:17]12[CH2:25][CH2:24][CH:21]([CH2:22][CH2:23]1)[N:20]([C:1]([O:2][C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[C:9]1[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=1)=[O:15])[CH2:19][CH2:18]2Participants
3
Procedure
Biphenyl-2-yl carbonochloridate (83.0 mg, 0.358 mmol) was treated with 1,4-diazabicyclo[3.2.2] nonane (113 mg, 0.896 mmol) using the same procedure reported in example 46 to afford the title compound as an off-white solid (17 mg, 15%). Purity: >99% UPLCMS (210 nm); retention time 0.75 min; (M+1) 323.
Sources & evidence
- ORD record
- ord-c4a1bed19504477f9da74557765f2946
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09126993B2
Reaction notes
Loading…